Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Kent Westbrook

Concepts (80)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
10
2015
1212
0.370
Why?
Lymph Nodes
5
2015
258
0.340
Why?
Sentinel Lymph Node Biopsy
5
2015
120
0.320
Why?
Carcinoma, Ductal, Breast
3
2015
90
0.220
Why?
Ultrasonography, Mammary
2
2015
61
0.200
Why?
Mastectomy, Segmental
2
2015
93
0.190
Why?
Melanoma
2
2016
288
0.170
Why?
Mastectomy
3
2015
143
0.170
Why?
Neoplasm Staging
5
2015
772
0.170
Why?
Nipples
2
2011
33
0.150
Why?
Dermatologic Surgical Procedures
2
2011
35
0.150
Why?
Skin Neoplasms
2
2016
505
0.150
Why?
Biopsy, Needle
2
2015
183
0.130
Why?
Axilla
4
2015
92
0.130
Why?
S100 Proteins
1
2016
34
0.130
Why?
Alopecia
1
2016
38
0.120
Why?
Carcinoma, Lobular
1
2015
32
0.120
Why?
Image-Guided Biopsy
1
2015
34
0.120
Why?
Neoplasm Recurrence, Local
2
2011
649
0.110
Why?
Neoplasm Proteins
1
2016
334
0.110
Why?
Head and Neck Neoplasms
1
2016
288
0.100
Why?
Aged
12
2016
10121
0.100
Why?
Lymphography
1
2011
10
0.090
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2011
46
0.090
Why?
Frozen Sections
1
2011
13
0.090
Why?
Receptors, Estrogen
2
2015
131
0.090
Why?
Mammaplasty
1
2011
43
0.090
Why?
Middle Aged
12
2016
13028
0.090
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1031
0.080
Why?
Lymphatic Metastasis
4
2015
220
0.080
Why?
Adult
10
2015
14161
0.070
Why?
Retrospective Studies
7
2015
6607
0.070
Why?
Lymphatic Vessels
1
2007
55
0.060
Why?
Receptor, erbB-2
1
2006
80
0.060
Why?
Carcinoma in Situ
1
2006
72
0.060
Why?
Female
12
2016
28171
0.060
Why?
Follow-Up Studies
4
2015
2279
0.060
Why?
Proliferating Cell Nuclear Antigen
1
2003
69
0.050
Why?
Laser Coagulation
1
2003
27
0.050
Why?
Aged, 80 and over
4
2015
3392
0.050
Why?
Sensitivity and Specificity
3
2011
891
0.050
Why?
Prospective Studies
3
2015
2481
0.040
Why?
Humans
12
2016
52483
0.040
Why?
Prognosis
3
2011
2099
0.040
Why?
Biopsy
2
2016
605
0.040
Why?
Treatment Outcome
3
2015
5422
0.030
Why?
Magnetic Resonance Imaging
1
2003
1546
0.030
Why?
Taxoids
1
2015
37
0.030
Why?
Technetium Tc 99m Sulfur Colloid
2
2007
31
0.030
Why?
Receptors, Progesterone
1
2015
66
0.030
Why?
Cyclophosphamide
1
2015
171
0.030
Why?
Lymph Node Excision
2
2007
133
0.030
Why?
Radiopharmaceuticals
2
2007
204
0.030
Why?
Neoadjuvant Therapy
1
2015
125
0.030
Why?
Carcinoma
1
2015
138
0.030
Why?
Angiogenesis Inhibitors
1
2015
183
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2015
236
0.030
Why?
X-Rays
1
2011
55
0.020
Why?
Reproducibility of Results
1
2015
1229
0.020
Why?
Cicatrix
1
2011
42
0.020
Why?
Intraoperative Period
1
2011
46
0.020
Why?
Young Adult
2
2011
4329
0.020
Why?
Stereotaxic Techniques
1
2010
40
0.020
Why?
Hematoma
1
2010
65
0.020
Why?
Neoplasm Invasiveness
1
2010
278
0.020
Why?
Double-Blind Method
1
2011
713
0.020
Why?
Ultrasonography, Interventional
1
2010
140
0.020
Why?
Adolescent
2
2011
6739
0.020
Why?
Coloring Agents
1
2007
69
0.020
Why?
Radionuclide Imaging
1
2007
107
0.020
Why?
Lymphedema
1
2007
48
0.020
Why?
Cohort Studies
1
2011
1542
0.020
Why?
Surgical Flaps
1
2005
110
0.010
Why?
Combined Modality Therapy
1
2006
639
0.010
Why?
Intraoperative Care
1
2002
51
0.010
Why?
Confidence Intervals
1
2002
158
0.010
Why?
Image Processing, Computer-Assisted
1
2003
253
0.010
Why?
Immunohistochemistry
1
2003
979
0.010
Why?
Predictive Value of Tests
1
2002
944
0.010
Why?
Male
1
2011
26761
0.010
Why?
Westbrook's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description